Zydus Lifesciences informs about press release
Zydus Lifesciences has informed that it enclosed a copy of press release dated April 8, 2026, titled ‘Zydus receives final approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg’.
The above information is a part of company’s filings submitted to BSE.
